ATLAS fair value
€207.63
Below fair value · 65% discount
Drägerwerk AG & Co. stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Xetra (Deutsche Börse) · Germany
Prices as of Oct 26, 2026 · EUR
€207.63
Below fair value · 65% discount
49%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Drägerwerk AG & Co.'s fair value at about €207.63 per share (reasonable range: €148.99 to €317.14). At €73.60, the stock trades 65% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Drägerwerk AG & Co. a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €67.94 and €79.32; in 9 out of 10, between €59.23 and €90.98. Estimated annual volatility is 48%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Drägerwerk AG & Co. sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks DRW8.XETRA has traded between €55.60 and €96.00. Today it is 23.3% below that high and 32% above its low.
On the business: net margin is 4.8%; it trades at 7.7 times earnings.
Its beta is 0.60: it tends to move less than the market.
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.
Want to see everything about Drägerwerk AG & Co.?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About €207.63 per share according to ATLAS (reasonable range: €148.99 to €317.14). With the stock at €73.60, it is 65% below it.
49%: close to a coin flip. In half of the simulated outcomes, DRW8.XETRA ends the month between €67.94 and €79.32.
Drägerwerk AG & Co.'s market capitalization is €1.7B. Its price-to-earnings (P/E) ratio is 7.7: you pay €7.65 for each €1.00 of yearly earnings.
Yes. DRW8.XETRA's current dividend yield is 3.17% at today's price (€73.60).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy